This study is for people with heart failure (HF) and impaired kidney function. Heart failure is when the heart doesn't pump blood as well as it should. Impaired kidney function means the kidneys don't filter blood properly. The study examines the effect of two medicines, balcinrenone/dapagliflozin and dapagliflozin, which may help improve heart and kidney health. Participants will take a pill once a day for about 20 months, along with a one-month follow-up.
The study will be conducted at about 700 locations in 40 countries. To join, participants must be 18 or older, have a recent HF event, and meet other medical criteria. Some conditions, like recent heart surgery or certain heart diseases, will prevent participation.
- Duration: The study lasts approximately 22 months.
- Visits: Participants will need regular check-ups.
- Risks: As with any study, there may be health risks, which will be explained by the doctors.
This study is important because it could help improve treatments for people with heart failure and kidney issues. If you meet the criteria and are interested, consult your doctor to see if joining this study is right for you.